600 results on '"Flatmark, Kjersti"'
Search Results
52. High expression of the cysteine proteinase legumain in colorectal cancer – Implications for therapeutic targeting
53. Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
54. Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases
55. T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases
56. Alginate Microsphere Encapsulation of Drug-Loaded Nanoparticles: A Novel Strategy for Intraperitoneal Drug Delivery
57. Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial
58. Corrigendum to “Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft”, [Journal of Control Release, 293 (2019) 183–192]
59. Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study
60. Clinical Significance of Long Intergenic Noncoding RNA-p21 in Colorectal Cancer
61. Molecular modelling and simulations in cancer research
62. A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer
63. Immunoregulatory protein B7‐H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cells
64. Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes
65. Abstract 2467: SPECT-imaging guided development and evaluation of targeted alpha therapy (TAT) for colorectal liver metastasis
66. Abstract 1346: T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases
67. Abstract 1279: Early radiologic signal of nivolumab responsiveness after short-course oxaliplatin-based chemotherapy in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC)
68. A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer
69. T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases.
70. Nuclear S100A4 is a novel prognostic marker in colorectal cancer
71. Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
72. Exploring the peritoneal surface malignancy phenotype—a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models
73. MicroRNAs as Biomarkers in Colorectal Cancer
74. MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohorts
75. Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
76. MR-guided simultaneous integrated boost in preoperative radiotherapy of locally advanced rectal cancer following neoadjuvant chemotherapy
77. Metastases in locally advanced rectal cancer undergoing curatively intended treatment
78. Abstract 522: Immunogenic chemotherapy and immune checkpoint inhibition (ICI) in microsatellite-stable (MSS) metastatic colorectal cancer (mCRC): Biomarkers indicative of durable treatment response
79. The delphi and GRADE methodology used in the PSOGI 2018 consensus statement on pseudomyxoma peritonei and peritoneal mesothelioma
80. Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
81. Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
82. Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination
83. Coexpression and nuclear colocalization of metastasis-promoting protein S100A4 and p53 without mutual regulation in colorectal carcinoma
84. TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins
85. Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients
86. Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?
87. Impact of Hyperthermia on Pharmacokinetics of Intraperitoneal Mitomycin C in Rats Investigated by Microdialysis
88. Corrigendum to “Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer” [Transl Oncol 12 (8) (2019) 1038–1044]
89. Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer
90. Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale
91. Repeat sequential oxaliplatin-based chemotherapy (FLOX) and nivolumab versus FLOX alone as first-line treatment of microsatellite-stable (MSS) metastatic colorectal cancer (mCRC): Initial results from the randomized METIMMOX study.
92. Omics analyses in peritoneal metastasis—utility in the management of peritoneal metastases from colorectal cancer and pseudomyxoma peritonei: a narrative review
93. Early Changes in Apparent Diffusion Coefficient Predict the Quantitative Antitumoral Activity of Capecitabine, Oxaliplatin, and Irradiation in HT29 Xenografts in Athymic Nude Mice
94. MirGeneDB 2.0 : the metazoan microRNA complement
95. Long-Term Oncologic Outcomes After Laparoscopic Versus Open Resection for Colorectal Liver Metastases
96. ImmunoPeCa trial: Long-term outcome following intraperitoneal MOC31PE immunotoxin treatment in colorectal peritoneal metastasis
97. The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma
98. Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies
99. B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer
100. A microRNA Signature of Metastatic Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.